Billionaire Stanley Druckenmiller Sold Nvidia and Palantir and Piled Into One of Wall Street's Hottest Drug Stocks Ahead of 2026
Duquesne Family Office's billionaire boss has jettisoned the faces of the artificial intelligence (AI) revolution in favor of a drugmaker whose shares have rallied 191% since the beginning of 2024.For the better part of the last three years, no trend has garnered more attention on Wall Street than artificial intelligence (AI). Empowering software and systems with the tools to make split-second decisions, all without the need for human oversight, is a technological advancement that can benefit most industrie ...